Skip to main content

Table 2 Baseline characteristics of study 2 participants

From: Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study

 

Baseline

Age

 Mean (SD)

29.7(11.5)

 Median (IQR)

27(21, 36)

Sex

 Male

36 (56%)

 Female

28 (44%)

FEV 1% Predicted

 Mean (SD)

57.3 (21.3)

 Median (IQR)

49.6 (41.9, 76.7)